| Toxicity . | Prophylaxis patients N = 47, n (%) . | Treatment patients N = 48, n (%) . |
|---|---|---|
| Leucopenia | ||
| WBC count <3.5 × 109/L | 8 (17); 8 SOT | 27 (56); 7 SOT and 20 HSCT |
| WBC count >20% decrease from baseline | 24 (51); 24 SOT | 24 (50); 7 SOT and 17 HSCT |
| Thrombocytopenia | ||
| platelet count <100 × 109/L | 17 (36); 17 SOT | 31 (65); 3 SOT and 28 HSCT |
| platelet count >50% decrease from baseline | 4 (9); 4 SOT | 9 (19); 1 SOT and 8 HSCT |
| Toxicity . | Prophylaxis patients N = 47, n (%) . | Treatment patients N = 48, n (%) . |
|---|---|---|
| Leucopenia | ||
| WBC count <3.5 × 109/L | 8 (17); 8 SOT | 27 (56); 7 SOT and 20 HSCT |
| WBC count >20% decrease from baseline | 24 (51); 24 SOT | 24 (50); 7 SOT and 17 HSCT |
| Thrombocytopenia | ||
| platelet count <100 × 109/L | 17 (36); 17 SOT | 31 (65); 3 SOT and 28 HSCT |
| platelet count >50% decrease from baseline | 4 (9); 4 SOT | 9 (19); 1 SOT and 8 HSCT |
WBC count normal range = 4–10 × 109/L.
Platelet count normal range = 150–400 × 109/L.
| Toxicity . | Prophylaxis patients N = 47, n (%) . | Treatment patients N = 48, n (%) . |
|---|---|---|
| Leucopenia | ||
| WBC count <3.5 × 109/L | 8 (17); 8 SOT | 27 (56); 7 SOT and 20 HSCT |
| WBC count >20% decrease from baseline | 24 (51); 24 SOT | 24 (50); 7 SOT and 17 HSCT |
| Thrombocytopenia | ||
| platelet count <100 × 109/L | 17 (36); 17 SOT | 31 (65); 3 SOT and 28 HSCT |
| platelet count >50% decrease from baseline | 4 (9); 4 SOT | 9 (19); 1 SOT and 8 HSCT |
| Toxicity . | Prophylaxis patients N = 47, n (%) . | Treatment patients N = 48, n (%) . |
|---|---|---|
| Leucopenia | ||
| WBC count <3.5 × 109/L | 8 (17); 8 SOT | 27 (56); 7 SOT and 20 HSCT |
| WBC count >20% decrease from baseline | 24 (51); 24 SOT | 24 (50); 7 SOT and 17 HSCT |
| Thrombocytopenia | ||
| platelet count <100 × 109/L | 17 (36); 17 SOT | 31 (65); 3 SOT and 28 HSCT |
| platelet count >50% decrease from baseline | 4 (9); 4 SOT | 9 (19); 1 SOT and 8 HSCT |
WBC count normal range = 4–10 × 109/L.
Platelet count normal range = 150–400 × 109/L.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
